Indeed, the specific migration towards CXCL12 was totally inhibited in MM cells pretreated with AMD (Figure 1A), a specific CXCR4 antagonist that inhibits the binding and function of CXCL12 with high affinity and potency [39]. This evidence concerns the gene CXCR4 and age-related macular degeneration.